Filing Details
- Accession Number:
- 0000905148-25-001866
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-20 16:59:06
- Reporting Period:
- 2025-05-16
- Filing Date:
- 2025-05-20
- Accepted Time:
- 2025-05-20 16:59:06
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604464 | Atara Biotherapeutics Inc. | ATRA | () |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
2064348 | Yanina Grant-Huerta | C/O Atara Biotherapeutics, Inc. 1280 Rancho Conejo Boulevard Thousand Oaks CA 91320 | Chief Accounting Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2025-05-16 | 2,218 | $6.76 | 37,067 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares sold automatically to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units, pursuant to a sale-to-cover provision in the award agreement.
- The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on May 16, 2025 and May 19, 2025 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.